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We found that 20.5% of patients with an unexplained 
fever  in  northwestern  Morocco  had  tick-borne  relapsing 
fever. Molecular detection specific for the 16S rRNA gene 
identified  Borrelia  hispanica.  The  noncoding  intergenic 
spacer sequence domain showed high sensitivity and good 
resolution for this species.
T
ick-borne relapsing fever (TBRF) is caused by Bor-
relia species transmitted to humans by infected ticks. 
This condition is frequently undiagnosed and its true in-
cidence is underestimated (1,2). TBRF is endemic to sub-
Saharan Africa, and the most prevalent Borrelia species in 
this region are B. duttonii in the eastern region and B. cro-
cidurae in the western  region (3–5). The disease is rarely 
detected in northern Africa and Mediterranean countries 
(3,6,7). B. hispanica and B. crocidurae infections have 
been detected in northern and southern Morocco, respec-
tively, along with the tick vectors responsible for their 
transmission (Ornithodoros  erraticus and O. sonrai, re-
spectively) (8). However, local transmission has not been 
detected in Morocco since the reports of Baltazard et al. in 
1954 (9) and Rodhain in 1976 (10), except for 1 traveler 
who returned from Spain and Morocco in 2005 with a B. 
hispanica infection (7).
Conventional diagnosis of TBRF is based on detection 
of spirochetes in blood smears sampled during the acute fe-
brile phase. However, molecular methods have been shown 
to be more reliable for diagnosis (6,7,11–13). We conduct-
ed retrospective and prospective surveys of patients with 
unexplained fever (suspected TBRF) in northwestern Mo-
rocco during 2000–2006 and used 2 genomic regions of 
Borrelia spp. to test blood samples from these patients.
The Study
We conducted a preliminary retrospective study during 
2000–2004. Results for Borrelia spp. screening, which was 
performed at the same time as diagnostic tests for malaria, 
were compiled retrospectively from 10 medical centers in 
the  Kenitra  District  of  northwestern  Morocco.  Borrelia 
spp. spirochetes were identified by observing 200 micro-
scope fields of Giemsa-stained thin blood smears under an 
oil-immersion objective (magnification ×1,000). Of 75,950 
patients, 84 had Borrelia spp. infections. On the basis of 
these results, we conducted active prospective surveillance 
in 6 medical centers that reported previous TBRF cases 
(Figure 1).
From January 2005 through December 2006, we in-
vestigated all patients with unexplained fever who did not 
have malaria. All patients were screened for Borrelia spp. 
infection by microscopy and molecular methods in 2005 
and only by molecular methods in 2006. Our study design 
conformed to directives concerning the conduct of clinical 
trials in Morocco.
DNA was extracted from whole blood sampled dur-
ing the febrile phase of the patients by using the DNeasy 
Tissue Kit (QIAGEN, Hilden, Germany). Two PCR meth-
ods were used. First, a seminested protocol specific for 
the entire 16S rRNA gene that used outer primers fD3 and 
T50 was conducted as described (11). The inner primers 
were REC4, as described (11), and RF16SR (5′-pos 867-
AGGCGCCACACTTAACACGT-3′-pos 847). REC4 and 
RF16SR were paired with T50 and fD3, respectively, to 
obtain 2 amplicons with a 208-bp overlap. These 2 con-
tigs were aligned to obtain the sequence of the entire 16S 
rRNA gene (1.5 kb). We then conducted a nested protocol 
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Figure 1. Locations in the Kenitra District of Morocco where tick-
borne relapsing fever was diagnosed. A, Sidi Mohamed Lahmar; 
B, Had Ouled Jelloum; C, Idrissi Kenitra; D, Lalla Mimouna; E, 
Mnasra; F, Sidi Taybi.Borrelia hispanica Relapsing Fever, Morocco
specific for the noncoding intergenic spacer region (IGS) 
as described (14). Two negative controls were included in 
all experiments: a negative extraction control and the PCR 
mixture without DNA. B. hermsii DNA was used as a posi-
tive control.
PCR products were sequenced on both strands by using 
Genome Express (Meylan, France) and the same primers as 
for amplification. All sequences determined in this study 
were  submitted  to  GenBank  (accession  nos.  FJ827568–
FJ827590 for IGS sequences and GQ202254–GQ202265 
for 16S rRNA sequences). Multiple sequence alignments 
were  generated  with  the  ClustalW  program  (www.ebi.
ac.uk/Tools/clustalw2/index.html).  Phylogenetic  analysis 
was conducted with MEGA software (www.megasoftware.
net) as described (11).
We included 127 patients in the prospective study. Bor-
relia spp. were detected in 10 (17.5%) of 57 patients in 2005 
and 16 (22.9%) of 70 patients in 2006 (mean prevalence 
rate 20.5%). The patients had not traveled outside Morocco. 
The most common signs and symptoms associated with fe-
ver were chills (88%), myalgia (61%), and gastrointestinal 
disorders,  such  as  diarrhea  and  vomiting  (54%).  Fifteen 
percent of the patients reported >1 relapse. Patients did not 
report any tick bites. All patients were successfully treated 
with doxycycline (100 mg/day for 7 days). Only 2 patients 
had a diagnosis of TBRF on the basis of microscopy; the 
diagnosis was confirmed by both PCR methods.
Results  for  molecular  detection  are  shown  in  the   
Table. All blood samples positive according to the 16S rRNA 
PCR assay were also positive according to the IGS PCR as-
say. The 26 patients positive for Borrelia spp. were from 
Had Ouled Jelloum and Sidi Mohamed Lahmar; 99 (78%) 
of the 127 patients were from these 2 sites. At Sidi Mo-
hamed Lahmar, the difference in PCR results for 16S rRNA 
and IGS remains unexplained. B. hispanica was identified 
by  BLAST  analyses  (www.ncbi.nlm.nih.gov/Education/
BLASTinfo/information3.html) of the entire 16S rRNA gene 
sequences from the 12 patients from whom we were able to 
amplify this gene. Ten of the 12 sequences were identical to 
the B. hispanica DQ057988 sequence from GenBank. The 2 
remaining sequences (GQ202254 and GQ202257) differed 
from this sequence by 1 nt (99.92% identity). Levels of sim-
ilarity between the 12 sequences from Morocco and other 
relapsing fever species sequences from Africa ranged from 
99.4% (2-nt difference) when compared with B. crocidurae 
DQ0057990 sequences to 99.35% (7-nt difference) when 
compared with B. recurrentis AF107362 sequences.
Phylogenetic analysis of 16S sequences showed single 
clusters for each relapsing fever species, with small dif-
ferences  between  African  species,  which  verified  previ-
ous results (Figure 2, panel A) (7,15). Although the IGS 
locus is not a coding sequence, the level of polymorphism 
among sequences from Morocco was low. Sequence iden-
tity ranged from 99.1% to 100%, with no more than 4-nt 
differences. We found 6 alleles among 23 IGS sequences. 
The shallow division between the 2 close branches of the 
IGS phylogenetic tree did not correspond to the 2 sites at 
which patients with B. hispanica relapsing fever were lo-
cated (Figure 2, panel B).
All  IGS  sequences  obtained  from  our  patients  were 
grouped in a single cluster separate from other Borrelia spp. 
responsible for TBRF. The sequences from Morocco differed 
from those of other species from Africa, such as B. crocidu-
rae (77.6% identity with B. crocidurae DQ000287 sequence) 
and the B. duttonii/B. recurrentis complex (75.5% identity 
with B. duttonii DQ000279/B. recurrentis DQ000277 se-
quences). Our results verify those of previous studies, which 
showed that IGS sequences cannot be used to differentiate 
B. recurrentis and B. duttonii from East Africa (15). Because 
the single IGS cluster, which included all sequences from 
Morocco, included the 12 B. hispanica identified by their 
16S sequences, we conclude that all 23 Borrelia spp. DNA 
samples identified in this study were B. hispanica.
Conclusions
The prevalence of B. hispanica TBRF was high in the 
Kenitra  District  of  northwestern  Morocco.  B.  hispanica 
was detected in 20.5% of patients with unexplained fever. 
This result may be explained by use of molecular methods 
for detection, selection of patients with unexplained fever, 
and living conditions in this region, in which persons live 
in traditional mud huts and grow groundnuts, particularly 
at Had Ouled Jelloum, where the highest frequency was 
observed (3,10).
Our series highlights the endemicity of TBRF in Mo-
rocco, but investigations in other districts are needed. Pa-
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 10, October 2009  1627 
Table. Results of PCR assays for detection of Borrelia spp. in 127 patients with unexplained fever in Kenitra, northwestern Morocco 
No. patients with positive results/total no. patients (%) 
Location 16S rRNA seminested PCR  Intergenic spacer sequence nested PCR 
Sidi Mohamed Lahmar  2/73 (2.7)  15/73 (20.0) 
Had Ouled Jelloum  10/26 (38.5)  11/26 (42.3) 
Idrissi Kenitra  0/8 0/8
Lalla Mimouna  0/12 0/12
Mnasra 0/3 0/3
Sidi Taybi  0/5 0/5
All 12/127 (9.4)  26/127 (20.5) tients living in Morocco and travelers returning from this 
country with unexplained fever should be tested for re-
lapsing fever caused by Borrelia spp. by using molecular   
methods.
We have shown that PCR amplification and sequencing 
of the IGS domain is a sensitive method with a high resolu-
tion level for detection of B. hispanica. This domain may 
also be useful for detection of other relapsing fever Borre-
lia spp., such as B. crocidurae, B. hermsii, B. turicatae, B. 
parkeri, and B. myamotoi. However, this method is not reli-
able for detection of B. recurrentis and B. duttonii, which 
cannot be differentiated by their IGS sequences (15).
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